Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial.
Xuewei XieJing JingXia MengS Claiborne JohnstonPhilip M BathZi-Xiao LiXing-Quan ZhaoYi-Long WangQin XuAnxin WangYong JiangHao LiYong-Jun Wangnull nullPublished in: Stroke (2024)
URL: http://www.clinicaltrials.gov. Unique identifier: NCT04078737.